Concept information
Preferred term
Memantine
Type
-
mesh:Descriptor
Definition
- AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.
Broader concept
Entry terms
- 1,3-Dimethyl-5-aminoadamantane
- 19982-08-2 (Memantine)
- 1-Amino-3,5-dimethyladamantane
- JY0WD0UA60
- Memantin
- Tricyclo(3.3.1.13,7)decan-1-amine, 3,5-dimethyl-
- W8O17SJF3T
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
19982-08-2 (Memantine)
-
JY0WD0UA60
-
Tricyclo(3.3.1.13,7)decan-1-amine, 3,5-dimethyl-
-
W8O17SJF3T
URI
http://data.loterre.fr/ark:/67375/JVR-FF48P6M8-1
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}